BREAST PUBLICATIONS 1990-2012

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

 

Wishart GC, Bajdik CD, Dicks E, Provenzano  E, Schmidt MK, Sherman M, Greenberg DC, Green AR, Gelmon KA, Kosma V-M, Olson JE, Beckmann MW, Winqvist R, Cross SS, Severi G, Huntsman D, Pylkäs K, Ellis I, Nielsen TO, Giles G, Blomqvist C, Fasching PA, Couch FJ, Rakha E, Foulkes WD, Blows FM, Bégin LR, van’t Veer LJ, Southey M, Nevanlinna H, Mannermaa A, Cox A, Cheang M, Baglietto L, Caldas C, Garcia-Closas M, Pharoah PDP.

Br J Cancer 2012; 107: 800-807.

 

Central breast excision with immediate latissimus dorsi reconstruction for recurrent periductal sepsis – an application of oncoplastic surgical techniques.

 

Gore S, Wishart GC, Malata CM.

ePlasty 2012; 12: 215-220.

 

A feasibility study (ICG-10) of indocyanine green (ICG) fluorescene mapping for sentinel lymph node biopsy in early breast cancer.

 

Wishart GC, Loh S-W, Britton PD, Jones L, Benson JR.

Eur J Surg Oncol 2012; 38(8): 651-6.

Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial.

MukeshM, BarnettG, CummingJ, WilkinsonJS, MoodyM, WilsonC, WishartGC and Coles  C.

Eur J Surg Oncol 2012, June 13 (Epub ahead of print)

 

How does imaging frequency and soft tissue motion affect the PTV margin size in partial breast and boost radiotherapy?

 

Harris EJ, Donovan EM,Coles CE, de Boer HCJ, Poynter A, Rawlings C, Wishart GC, Evans  PM. On behalf of the IMPORT trialists.

Radiother Oncol 2012; 103(2): 166-71

 

The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups.

 

Curtis C, Shah SP, Chin S_F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC group, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale A-L, Brenton J, Tavare S, Caldas C, Aparicio S.

Nature. 2012; 486(7403): 346-52.

 

Randomised controlled trial of forward-planned Intensity Modulated Radiotherapy (IMRT) for early breast cancer: interim results at 2 years.

 

BarnettGC, WilkinsonJC, MoodyAM, WilsonCB, TwymanN, WishartGC, BurnetNG, ColesCE.

Int J Radiol, Biol, Phys. 2012; 82(2): 715-23.

 

Measuring the accuracy of breast imaging in symptomatic patients: team and individual performance.

 

Britton P, Warwick J, Wallis MG. Sinnatamby R, O’Keefe S, Taylor K, Barter S, Gaskarth M, Duffy SW, Wishart GC.

Br J Radiol 2012; 85:415-422.

 

Role of axillary clearance for patients with sentinel node-positive early breast

cancer.

 

Benson JR, Wishart GC. Br J Surg 2011; 98(11): 1499-1500

 

The Cambridge Breast IMRT trial: patient and treatment-related risk factors for

the development of normal tissue toxicity.

 

Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnett

NG, Coles CE. Clin. Oncol. (R Coll Radiol.), 2011; 23(10): 662-673.

 

Evaluation of implanted gold seeds for breast radiotherapy planning and on

treatment verification: a feasibility study on behalf of the IMPORT trialists.

 

Coles CE, Harris EJ, Donovan EM, Bliss P, Evans PM, Fairfoul J, Mackenzie C,

Rawlings C, Syndikus I, Twyman N, Vasconcelos J, Vowler SL, Wilkinson JS, Wilks R, Wishart GC, Yarnold J. Radiother. Oncol. April 2011 2011: 100(2): 276-281.

 

Population-based validation of prognostic model PREDICT for early breast cancer.

 

Wishart GC, Bajdik CD, Azzato EM, Dicks E, Greenberg DC, Rashbass J, Caldas C,

Pharoah PDP. Eur J Surg Oncol. 2011; 37: 411-417.

  

 

Patient and tumour characteristics, management, and age-specific survival in

women with breast cancer in the East of England.

 

Ali AMG, Wishart GC, Pharoah PDP. Br J Cancer 2011; 104: 564-570.

 

Is intra-operative nodal assessment essential in a modern breast practice?

 

Benson JR & Wishart GC. Eur J Surg Oncol. 2010; 36(12): 1162-1164.

 

Breast cancer: advances in risk assessment.

 

Wishart GC. Practice Nursing 2010; 21 (10): 511-514.

 

Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer

 

Liau S-S, Cariati M, Noble D, Wilson C, Wishart GC. Ann R Coll Surg Engl 2010; 92: 562-568.

 

The accuracy of digital infrared imaging for breast cancer detection in women

undergoing breast biopsy.

 

Wishart GC, Campisi M, Boswell M, Chapman D, Shackleton V, Iddles S, Hallett A,

Britton PD. Eur J Surg Oncol.2010; 36(6): 562-568.

 

Measuring performance in clinical breast examination.

 

Wishart GC, Warwick J, Pitsinis V, Duffy S, Britton PD.

Br J Surg 2010; 97(8): 1246-52.

 

New technological developments in the diagnosis and surgical management of breast cancer.

 

Pitsinis V & Wishart GC. Hellenic Journal of Surgery 2010, 82(1): 66-69.

 

PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer.

 

Wishart GC, Azzato EM, Pharoah PDP, Greenberg DC, Rashbass R, Kearins O,

Lawrence G, Caldas C, Ravdin PM. Breast Cancer Res. 2010, Jan 6; 12(1): R1

 

Treatment and survival in breast cancer in the Eastern Region of England.

 

Wishart GC, Greenberg DC, Chou P, Duffy S, Brown CH, Purushotham AD.

Ann. Oncol. 2010; 21(2): 291-6.

 

Introduction to sessions on guidelines & endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer.

 

Wishart GC & Chetty U. Breast Cancer Res. 2009; 11 (suppl 3): S17.

 

A metadata approach for clinical data management in translational genomics

studies in breast cancer.

 

Papatheodorou I, Crichton C, Morris L, METABRIC Group, Davies J, Brenton JD,

Caldas C. BMC Med Genomics 2009; 2: 66

 

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.

 

Dawson SJ, Duffy SW, Blows FM, Driver KE, Provenzano E, LeQuesne J, Greenberg DC, Pharoah P, Caldas C, Wishart GC. Br J Cancer 2009; 101(8): 1338-44.

 

Radiological staging in breast cancer: which asymptomatic patients to image and how.

 

Barrett T, Bowden DJ, Greenberg DC, Brown CH, Wishart GC, Britton PD.

Br J Cancer 2009; 101: 1522-1528.

 

Tamoxifen: the drug that came in from the cold.

 

Hughes-Davies L, Caldas C, Wishart GC. Br J Cancer 2009; 101: 875-878.

 

One-stop diagnostic breast clinics: how often are breast cancers missed?

 

Britton PD, Duffy S, Sinnatamby R, Wallis M, Barter S, O’Neill A, Carlos C, Brenton

JD, Forouhi P, Wishart GC. Br J Cancer 2009; 100: 1873-1878.

 

Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery– audit on behalf of the IMPORT Trial Management Group.

 

Coles CE, Cumming J, Benson JR, Forouhi P, Wilkinson JS, Wilson CB, Wishart GC. Eur J Surg Oncol. 2009; 35(6): 578-582.

 

Patient led breast cancer follow up.

 

Chapman D, Cox E, Britton PD, Wishart GC. The Breast 2009; 18: 100-102.

 

Comparison of the incidence of severe capsular contracture following implant-based immediate reconstruction with or without postoperative chest wall radiotherapy using 40Gy in 15 fractions.

 

Whitfield GA, Horan G, Irwin MS, Malata CM, Wilson CB, Wishart GC.

Radiotherapy & Oncology 2009; 90(1): 141-147.

 

Metabolic-Flow Relationships in Primary Breast Cancer: Feasibility with Combined PET/ Dynamic Contrast Enhanced CT.

 

Groves AM, Wishart GC, Shastry M, Moyle P, Iddles S, Britton PD, Gaskarth M,

Warren RML, Ell PJ, Miles KA. Eur J Nul Med & Mol Imaging 2009; 36(3): 416-421.

 

Ultrasound-guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied?

 

Britton P D, Provenzano E, Barter S, Gaskarth M, Goud A, Moyle P, Sinnatamby R,

Wallis M, Benson J R, Forouhi P, Wishart GC. The Breast 2009; 18(1): 13-16.

 

Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer.

 

Britton PD, Goud A, Godward S, Barter S, Freeman A, Gaskarth M, Rajan P,

Sinnatamby R, Slattery J, Provenzano E, O’Donovan M, Pinder S , Benson J, Forouhi P, Wishart GC. European Radiology 2009; 19: 561-569

 

Screen-detected versus symptomatic breast cancer-is improved survival due to stage migration alone?

 

Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duffy SW. Br J Cancer 2008; 98: 1741-1744.

 

On behalf of the Import Working Group. The IMPORT Gold Seed Study:

Evaluation of Tumour Bed Localisation and Image-guided Radiotherapy for Breast Cancer.

 

Coles CE, Wishart GC, Donovan E, Harris E, Poynter A, Twyman N, Routsis D,

Wilkinson J, Yarnold J. Clin Oncol (R Coll Radiol). 2007 Apr;19(3):S26-7.

 

NEW START: the UK SLNB training programme-a progress report.

 

MacNeill F. On behalf of the NEW START Steering Group. Ann R Coll Surg Engl 2007, 89 (suppl): 60-61.

 

Clip placement during axillary clearance.: defining the radiotherapy target.

 

Horan G, Rafique, Wishart GC, Wilson CB Clin Oncol. 2006; 18: 721-2.

 

Post-operative complications following subareolar duct clearance.

 

Chapman D , Bennett Britton TM, , Purushotham AD, Wishart GC.

Cancer Nursing Practice 2006; 5(5): 36-39.

 

Advances in axillary surgery for breast cancer – time for a tailored approach.

 

Purushotham AD, Macmillan RD, Wishart GC. Eur J Surg Oncol. 2005 Nov; 31(9):929-31

 

Morbidity after sentinel node biopsy in primary breast cancer: a randomized

controlled trial.

 

Purushotham AD, Upponi S, Klevesath M et al on behalf of the Cambridge/East Anglia Study Group. J Clin Oncol 2005; 23: 4312-4321

 

Nurse specialists in breast care: a developing role.

 

Burnet KL, Wishart GC, Purushotham AD, Chapman DE. Nursing Standard 2004; 18: 38-42

 

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

 

Warren RML, Bobrow LG, Earl HM, Britton PD, Gopalan D, Purushotham AD,

Wishart GC, Benson J, Hollingworth W. Br J Cancer 2004; 90(7): 1349-60.

 

An audit of nurse practitioner training in breast and axillary examination.

 

Chapman D, Purushotham AD, Wishart GC. Nursing Standard 2002; 17(2): 33-36.

 

Sentinel lymph node biopsy in breast cancer – is lymphoscintigraphy really

necessary?

 

Upponi SA, McIntosh S, Wishart GC, Balan KK, Purushotham AD. Eur J Surg Oncol 2002; 28: 479-480

 

The management of radial scars of the breast – does core biopsy help?

 

Britton PD, Wishart GC, Ravichandran D, McIntosh S, Bobrow L, Purushotham AD.

J BUON 2002; 7: 137-140

 

Hormone receptor status in primary breast cancer – time for consensus?

 

Wishart GC, Gaston M, Poultsidis AA, Purushotham AD. Eur J Cancer 2002; 38(9): 1201-1203

 

The management of patients with intermediate (AC3) Cytology and a solitary breast lump.

 

Mander BJ, Berresford PA, Tildsley G, Qureshi T & Wishart GC. The Breast 2001; 10: 163-165

 

Anatomical variants of the intercostobrachial nerve encountered during axillary dissection.

 

Cunnick GH, Upponi S & Wishart GC. The Breast 2001; 10: 160-162

 

Sentinel lymph node biopsy in impalpable breast cancer.

 

McIntosh S, Ravichandran D, Balan KK, Bobrow L, Wishart GC, Purushotham AD.

The Breast 2001; 10: 82-83

 

Lobular carcinoma in situ – what is the clinical significance?

 

O’Driscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R. Clinical Radiology Mar 2000; 56(3): 216-220

 

Junior doctor training in breast and axillary examination – a comparative study.

 

Cunnick GH, Upponi S & Wishart GC. The Breast 2000; 9: 312–314

 

Medical and psychological effects of early discharge after surgery for breast cancer.

 

Mander BJ Cunnick GH, Daultrey M, Wishart GC. BMJ 1998; 317: 1081-1082

 

The importance, availability and measurement of oestrogen receptor (ER) status in the management of breast cancer in the United Kingdom – results of a nationwide survey.

 

Mander BJ, Heal K, Purushotham AD, Wishart GC. The Lancet 1998; 352: 36-37

 

Oestrogen receptor status – no longer an optional extra.

 

Wishart GC, Harnett AN, Purushotham AD. The Breast 1998; 7: 154-155

 

Epirubicin chemotherapy for advanced breast cancer after adjuvant CMF

chemotherapy.

 

Bissett D, Paul J, Wishart GC, Jodrell D, Machem MA, Harnett AN, Canney PA, George WD, Kaye SB. Clin Oncol (Royal College of Radiologists) 1995; 7(1): 12-15

 

Quinidine as a resistance modulator of epirubicin in advanced breast cancer:

mature results of a placebo-controlled, randomised trial.

 

Wishart GC, Bisset D, Paul J, Jodrell D, Harnett AN, Habeshaw T, Kerr DJ, Machem

MA, Soukop M, Leonard RCF, Knepil J, Kaye SB. J Clin Oncol 1994; 12: 1771-1777

 

Identification of multidrug resistance modulators with clinical potential by analysis of synergistic activity in vitro and in vivo.

 

Plumb JA, Wishart GC, Setanoians A, Bicknell SR, Hamilton T, Kaye SB.

Biochem Pharmacol 1994; 47 257-266

 

Co-amplification of ERBB2, topisomerase II-alpha and retinoic acid receptor genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.

 

Keith WN, Douglas F, Wishart GC, McCallum HM, George WD, Kaye SB, Brown R.

Eur J Cancer 1993; 29 (10): 1469-1475

 

Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and treated patients.

 

Milroy R, Plumb JA, Batstone P, Maclay A, Wishart GC, Candlish W, Adamson R, Hay FG, Khan MZ, Banham S, Kaye SB. Anticancer Research 1992; 12: 193-200

 

Adequate tumour quinidine levels for multidrug resistance modulation can be

achieved in vivo.

 

Wishart GC, Plumb JA, Morrison JG, Hamilton TG, Kaye SB.

Eur J Cancer 1992; 28: 28-31

 

Is multidrug resistance relevant in breast cancer?

 

Wishart GC, Kaye SB. Eur J Surg Oncology 1991; 17: 485-488

 

H-ras transfection in mink lung epithelial cells may induce “atypical” multidrug

resistance.

 

Wishart GC, Plumb JA, Spandidos DA, Kerr DJ. Eur J Cancer 1991; 27: 673

 

P-glycoprotein expression in primary breast cancer detected by

immunocytochemistry with two monoclonal antibodies.

 

Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T, Kaye SB.

Br J Cancer 1990; 62: 758-761